Chromocell Therapeutics Corp (CIK: 0001919246) EDGAR, Information, Filings... CompaniesBIO.Com

Chromocell Therapeutics Corp

Mailing address
685 US HIGHWAY ONE, NORTH BRUNSWICK, Delaware, 08902
Phone
9176446313
State location
New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Chromocell Therapeutics Corp (CIK: 0001919246) is an American company incorporated in the state of New Jersey. Head office is located at 685 US HIGHWAY ONE, NORTH BRUNSWICK, New Jersey, 08902. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Chromocell Therapeutics Corp is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Chromocell Therapeutics Corp

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G	Document	Acc-no: 0000950170-25-020833 (34 Act) Size: KB	Feb-14-2025	005-94460 25626039
SCHEDULE 13G	Document	Acc-no: 0001213900-25-003922 (34 Act) Size: KB	Jan-15-2025	005-94460 25533780
EFFECT	Document	Acc-no: 9999999995-24-003826 (33 Act) Size: KB	Dec-19-2024	333-269188 241564885
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001753926-24-002067 ( Act) Size: KB	Dec-11-2024
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001753926-24-002065 (33 Act) Size: KB	Dec-11-2024	333-269188 241541581
UPLOAD	Document	Acc-no: 0000000000-24-013421 ( Act) Size: KB	Dec-05-2024	333-269188
EFFECT	Document	Acc-no: 9999999995-24-003629 (33 Act) Size: KB	Dec-02-2024	333-281070 241520875
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001753926-24-001987 (33 Act) Size: KB	Nov-22-2024	333-281070 241490302
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001753926-24-001985 (33 Act) Size: KB	Nov-22-2024	333-269188 241490230
8-K	Document	Current report filing Acc-no: 0001753926-24-001983 (34 Act) Size: KB	Nov-21-2024	001-41964 241482288
8-K12G3	Document	Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(g) Acc-no: 0001753926-24-001960 (34 Act) Size: KB	Nov-19-2024	000-56708 241473041
8-K	Document	Current report filing Acc-no: 0001753926-24-001955 (34 Act) Size: KB	Nov-18-2024	001-41964 241472278
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-24-001951 ( Act) Size: 0 KB	Nov-15-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-24-001949 ( Act) Size: 0 KB	Nov-15-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-24-001947 ( Act) Size: 0 KB	Nov-15-2024
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-001887 (33 Act) Size: KB	Nov-13-2024	333-269188 241455713
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-001885 (33 Act) Size: KB	Nov-13-2024	333-269188 241455639
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001753926-24-001883 (34 Act) Size: KB	Nov-13-2024	001-41964 241454906
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-001882 (34 Act) Size: KB	Nov-13-2024	005-94460 241454041
8-K	Document	Current report filing Acc-no: 0001753926-24-001759 (34 Act) Size: KB	Oct-24-2024	001-41964 241390821

Recent 20 filings. View all Chromocell Therapeutics Corp filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Chromocell Therapeutics Corp overview
Chromocell Therapeutics Corp job
Chromocell Therapeutics Corp stock
Chromocell Therapeutics Corp ownership
Chromocell Therapeutics Corp CEO
Chromocell Therapeutics Corp documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.